SANUWAVE Health, Inc.
SNWV
$32.21
$0.8852.83%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 41.92% | 61.46% | 47.64% | 88.98% | 53.20% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 41.92% | 61.46% | 47.64% | 88.98% | 53.20% |
| Cost of Revenue | 14.78% | 23.61% | 5.84% | 62.39% | 59.90% |
| Gross Profit | 51.87% | 75.73% | 66.31% | 99.58% | 50.88% |
| SG&A Expenses | 98.85% | 22.23% | 48.50% | 27.61% | 29.65% |
| Depreciation & Amortization | -3.33% | 5.49% | 16.93% | 10.16% | -3.74% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 60.29% | 22.24% | 31.05% | 35.07% | 38.09% |
| Operating Income | -5.77% | 193.90% | 142.73% | 467.80% | 113.96% |
| Income Before Tax | -83.92% | -25.35% | -169.75% | 12.84% | 190.35% |
| Income Tax Expenses | -- | -- | 575.00% | -- | -- |
| Earnings from Continuing Operations | -83.92% | -25.35% | -169.91% | 12.84% | 190.35% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -83.92% | -25.35% | -169.91% | 12.84% | 190.35% |
| EBIT | -5.77% | 193.90% | 142.73% | 467.80% | 113.96% |
| EBITDA | -8.58% | 230.74% | 127.74% | 930.45% | 89.47% |
| EPS Basic | -94.08% | 54.55% | -124.92% | 34.84% | 144.50% |
| Normalized Basic EPS | -68.95% | 53.47% | -127.05% | 34.84% | 108.49% |
| EPS Diluted | -99.60% | 54.55% | -124.92% | 34.84% | 137.85% |
| Normalized Diluted EPS | -65.97% | 53.47% | -127.05% | 34.84% | 107.23% |
| Average Basic Shares Outstanding | 171.58% | 175.79% | 180.57% | 33.77% | 103.01% |
| Average Diluted Shares Outstanding | 147.81% | 175.79% | 180.57% | 33.77% | 138.23% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |